Evaluation of α-tocopherol contained in plasma lipoproteins: How should the data be expressed? [1]

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 15, Issue 3, 2005, Pages 234-237

  Brites, Fernando ^a   Gambino, Guillermo ^a   Wikinski, Regina ^a   Evelson, Pablo ^a   Travacio, Marina ^a   Llesuy, Susana ^a  

^a Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; VERY LOW DENSITY LIPOPROTEIN;

EVALUATION; HUMAN; LETTER; LIPOPROTEIN BLOOD LEVEL; OXIDATION; OXIDATIVE STRESS; RANK SUM TEST; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRACENTRIFUGATION; VENOUS BLOOD;

EID: 21644466900     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2004.10.004     Document Type: Letter

References (17)

1. Papas A, Vos E. Vitamin E, cancer, and apoptosis. Am J Clin Nutr 2001;73:1113-4.
2. Stampfer M, Hennekens C, Manson J, Colditz G, Rosner B, Willett W. Vitamin E consumption and the risk of coronary disease in human. N Engl J Med 1993;328:1444-9.
3. Marchioli R. Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data. Pharmacol Res 1999;40:227-38.
4. Pryor WA. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000;28:141-64.
5. Behrens WA, Thompson JN, Madère R. Distribution of α-tocopherol in human plasma lipoproteins. Am J Clin Nutr 1982;35:691-6.
6. Carcelain G, David F, Lepage S, Bonnefont-Rousselot D, Delattre J, Legrand A, et al. Simple method for quantifying α-tocopherol in low-density + very-low-density lipoproteins and in high-density lipoproteins. Clin Chem 1992;38:1792-5.
7. Schumaker VN, Puppione DL. Sequential flotation ultracentrifugation. Methods Enzymol 1986;128:155-70.
8. Noble RP. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res 1968;9:693-700.
9. Lang JK, Gohil K, Packer L. Simultaneous determination of tocopherols, ubiquinols, and ubiquinonesin blood, plasma, tissue homogenates, and subcellular fractions. Anal Biochem 1986;157:106-16.
10. Vieira OV, Laranjinha JAN, Madeira VMC, Almeida LM. Rapid isolation of low density lipoproteins in a concentrated fraction free from water-soluble plasma antioxidants. J Lipid Res 1996;37:2715-21.
11. Chappey B, Myara I, Benoit MO, Mazière C, Mazière JC, Moatti N. Characteristics of ten charge-differing subfractions isolated from human native low-density lipoproteins (LDL). No evidence of peroxidative modifications. Biochim Biophys Acta 1995;1259:261-70.
12. Goulinet S, Chapman MJ. Plasma LDL and HDL subspecies are heterogeneous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis. Arterioscler Thromb Vasc Biol 1997;17:786-96.
13. de Graff J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendricks JCM, Stalenhoef AFH. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arteriosclerosis 1991;11:298-306.
14. Mackness MI, Arrol S, Turrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 1991;286:152-4.
15. Perugini C, Bagnati M, Cau C, Bordone R, Paffoni P, Re R, et al. Distribution of lipid-soluble antioxidants in lipoproteins from healthy subjects. I. Correlation with plasma antioxidant levels and composition or lipoproteins. Pharmacol Res 2000;41:55-65.
16. Lee SJ, Campos H, Moye LA, Sacks FM. LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients. Arterioscler Thromb Vasc Biol 2003;23:253-8.
17. Moberly JB, Attman PO, Samuelsson O, Johansson AC, Knight-Gibson C, Alaupovic P. Alterations in lipoprotein composition in peritoneal dialysis patients. Perit Dial Int 2002;22:220-8.